Showing 541 - 560 results of 11,927 for search '"Hepatocellular carcinoma"', query time: 0.19s Refine Results
  1. 541
  2. 542
  3. 543

    Puzzling out the role of MIAT LncRNA in hepatocellular carcinoma by Rawan Amr Elmasri, Alaa A. Rashwan, Sarah Hany Gaber, Monica Mosaad Rostom, Paraskevi Karousi, Montaser Bellah Yasser, Christos K. Kontos, Rana A. Youness

    Published 2024-06-01
    “…In the current review, the authors highlight the multifaceted role of myocardial infarction-associated transcript (MIAT), a well-known lncRNA, in hepatocellular carcinoma (HCC). Since its discovery, MIAT has been described as a regulator of carcinogenesis in several malignant tumors and its overexpression predicts poor prognosis in most of them. …”
    Get full text
    Article
  4. 544
  5. 545
  6. 546
  7. 547
  8. 548
  9. 549
  10. 550

    Multicentric Fibrolamellar Hepatocellular Carcinoma: A Rare Case Report by Mayank Goyal, Komerisetty Rozaih, Salil Bhargava, Swapnil Sheth, Samarjit Singh Ghuman, Tarvinder B. S. Buxi

    Published 2023-01-01
    “…Multicentric fibrolamellar hepatocellular carcinoma has not been reported yet in the world as of our knowledge. …”
    Get full text
    Article
  11. 551

    Adherence to Tumor Board Recommendations in the Treatment of Patients with Hepatocellular Carcinoma by Cao Y, Mezzacappa C, Jaffe A, Strazzabosco M, Taddei TH

    Published 2023-05-01
    “…Yueming Cao,1 Catherine Mezzacappa,1,2 Ariel Jaffe,1,2 Mario Strazzabosco,1,2 Tamar H Taddei1,2 1Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; 2Department of Internal Medicine Digestive Disease Section, Yale School of Medicine, New Haven, CT, USACorrespondence: Tamar H Taddei, Department of Internal Medicine, Yale School of Medicine, PO Box 208019, New Haven, CT, 06520-8019, USA, Tel +1 203-785-7312, Fax +1 203-785-7273, Email tamar.taddei@yale.eduBackground: Hepatocellular carcinoma (HCC) is a heterogeneous disease that typically arises in the setting of chronic liver disease, making treatment selection complex. …”
    Get full text
    Article
  12. 552
  13. 553
  14. 554
  15. 555
  16. 556
  17. 557

    Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics by Zhao Li, Ming Guan, Yu Lin, Xiao Cui, Yangyang Zhang, Zhenwen Zhao, Jiye Zhu

    Published 2017-11-01
    “…Background: The aim of this study was to characterize the disorder of lipid metabolism in hepatocellular carcinoma (HCC). HCC is a worldwide disease. …”
    Get full text
    Article
  18. 558
  19. 559

    Association of elevated autoantibody to high expression of GNAS in hepatocellular carcinoma by Keyan Wang, Cuipeng Qiu, Mengtao Xing, Miao Li, Bofei Wang, Hua Ye, Jianxiang Shi, Liping Dai, Xiao Wang, Peng Wang

    Published 2023-12-01
    “…Purpose: This study was based on hepatocellular carcinoma (HCC) patients of early-stage to explore the diagnostic capability and possible production causes of anti-GNAS autoantibody. …”
    Get full text
    Article
  20. 560